Skip to main contentAI and Advanced
/
NEXUSSURGL · BSEBSE SENSEX74,336.45+0.45%BSE |
NIFTY 5023,217.6+0.43%NSE |
NIFTY BANK56,292.45+0.89%NSE |
NIFTY IT29,087.65-1.58%NSE |
NIFTY AUTO26,893.65+0.51%NSE |
NIFTY FMCG45,559+1.63%NSE |
NIFTY PHARMA26,146.2-0.16%NSE |
NIFTY 50022,532+0.24%NSE |
NE
BSE · Equity shares · Other Financial Services-1.06 · -3.10%
Nexus Surgical And Medicare Ltd NEXUSSURGL
NSE:Not available
BSE:INR 33.09
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for NEXUSSURGL
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 34.15
Day rangeINR 32.45 — INR 35.79
52-week rangeINR 17 — INR 35.79
Volume10,588
Market cap18.11
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)2.55
Net Income (INR Cr)0.2
EPS0.37
Research path: Interpret Nexus Surgical And Medicare Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
NEXUSSURGLNexus Surgical And Medicare Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Jun-26 | Mar-26 | FY25-26 |
|---|---|---|---|
| Revenue | 2.55 | 2.05 | 7.87 |
| Net Profit | 0.2 | 0.24 | 0.74 |
| EPS | 0.37 | 0.44 | 1.35 |
| Cash EPS | 0.37 | 0.44 | 1.35 |
| OPM % | 10.75 | 15.64 | 12.61 |
| NPM % | 8.01 | 11.73 | 9.35 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m10.75
Net Profit Margin 12m8.01
Valuation
Price to Sale Ratio7.10
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 18.73%
- Public shareholders
- 81.27%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Reply On Clarification Sought By ExchangeBSE corporate filing · 3 Sept 2026, 5:30 am
Reg. 34 (1) Annual Report.BSE corporate filing · 3 Sept 2026, 5:30 am
Notice Of The 35Th Annual General Meeting Of The Company To Be Held On Friday, 25Th September, 2026 At 12:30 P.M. Through Video Conferencing (VC)BSE corporate filing · 3 Sept 2026, 5:30 am
Annual General Meeting To Be Held On Friday, 25Th September, 2026 At 12:30 P.M. Through Video Conferencing (VC)BSE corporate filing · 2 Sept 2026, 5:30 am
Announcement Under Regulation 30 - Reconstitution Of CommitteesBSE corporate filing · 2 Sept 2026, 5:30 am
Announcement Under Regulation 30 - Reappointment Of Independent Director For A Second Term Of 5 YearsBSE corporate filing · 2 Sept 2026, 5:30 am
Corporate actions
Events
- board MeetingsA.G.M.
- board MeetingsGeneral
- board MeetingsGeneral
- board MeetingsResults
- board MeetingsGeneral
- board MeetingsResults
- board MeetingsResults
- board MeetingsResults
Rusaka Markets Community
Discussion and sentiment for Nexus Surgical And Medicare Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Other Financial Services
- Sector
- Financial Services
- Website
- www.nexusmed.co.in
- Address
- Gala No.4, Saarthak, Building No. 1, Square Industrial Park, Tungarphata, Vasai (East), Palghar , Maharashtra, 401208
- NSE Code
- NEXUSSURGL
- BSE Code
- 538874
- Listing date
- 8 Jan 2015
- Face value
- 10
- Market lot
- 1
- CIN
- L33100MH1992PLC328367
- Company email
- nexuscomm92@gmail.com
- Company phone
- 8433598185
Leadership and officers
- Executive Director & Chief Financial Officer
- Mr. Pawankumar Sitaram Choudhary
- Non - Executive Independent Director
- Mr. Surya Kant Modi
- Independent Non-Executive Woman Director
- Ms. Neha Kailash Bhageria
- Non - Executive Independent Director
- Mr. Ashish Durgaprasad Mishra
- Executive Director
- Mr. Anish More
- Company Secretary cum Compliance Officer
- Ms. Monika Pawankumar Choudhary
Questions
Stock FAQ
What is the symbol and ISIN of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has the symbol NEXUSSURGL and ISIN - INE370Q01015.
What is the current price of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd is currently trading at INR 33.09.
What are the year high and year low of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a year high of INR 35.79 and a year low of INR 17.00.
What is the market capitalization of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a market capitalization of INR 18.11 crore.
What is the P/E ratio of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a P/E ratio of NA.
What is the dividend yield of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a dividend yield of NA.
How is the financial performance of Nexus Surgical And Medicare Ltd based on revenue, net income, and EPS?
Nexus Surgical And Medicare Ltd has revenue of INR 2.55 crore, net income of INR 0.20 crore, and EPS of NA.
What is the book value of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a book value of NA.
What is the debt-to-equity ratio of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Nexus Surgical And Medicare Ltd?
Nexus Surgical And Medicare Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 7.10.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.